Literature DB >> 17254819

Cerebellar atrophy without cerebellar cortex hyperintensity in infantile neuroaxonal dystrophy (INAD) due to PLA2G6 mutation.

Roberta Biancheri1, Andrea Rossi, Giannina Alpigiani, Mirella Filocamo, Carlo Gandolfo, Renata Lorini, Carlo Minetti.   

Abstract

Infantile neuroaxonal dystrophy (INAD) is a rare neurodegenerative disorder characterized by infantile onset and rapid progression of psychomotor regression and hypotonia evolving into spasticity. The neuroradiologic hallmark of the disease is represented by cerebellar atrophy and signal hyperintensity in the cerebellar cortex on MR T2-weighted images. We report a 2-year-old boy with psychomotor regression and hypotonia carrying a homozygous 5' splice site mutation in PLA2G6 gene, whose brain MRI revealed cerebellar atrophy with normal cerebellar cortex signal intensity. The absence of the signal hyperintensity of the cerebellar cortex does not rule out the diagnosis of INAD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17254819     DOI: 10.1016/j.ejpn.2006.11.013

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  13 in total

Review 1.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

2.  Molecular diagnosis of infantile Neuro axonal Dystrophy by Next Generation Sequencing.

Authors:  Manisha Goyal; Sunita Bijarnia-Mahay; Stephen Kingsmore; Emily Farrow; Carol Saunders; Renu Saxena; Ishwar C Verma
Journal:  Indian J Pediatr       Date:  2014-10-29       Impact factor: 1.967

3.  Monozygotic twins with infantile neuroaxonal dystrophy: A case report and literature review.

Authors:  Haifeng Li; Yan Zou; Xinhua Bao; Hui Wang; Jiangping Wang; Huiying Jin; Yuping Che; Xiaoyan Tang
Journal:  Exp Ther Med       Date:  2016-09-30       Impact factor: 2.447

Review 4.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

5.  Evidence for proteolytic processing and stimulated organelle redistribution of iPLA(2)beta.

Authors:  Haowei Song; Shunzhong Bao; Xiaoyong Lei; Chun Jin; Sheng Zhang; John Turk; Sasanka Ramanadham
Journal:  Biochim Biophys Acta       Date:  2010-02-02

Review 6.  Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.

Authors:  Xiaoyong Lei; Suzanne E Barbour; Sasanka Ramanadham
Journal:  Biochimie       Date:  2010-01-18       Impact factor: 4.079

7.  Validation of the finding of hypertrophy of the clava in infantile neuroaxonal dystrophy/PLA2G6 by biometric analysis.

Authors:  A Al-Maawali; G Yoon; A S Feigenbaum; W C Halliday; J T R Clarke; H M Branson; B L Banwell; D Chitayat; Susan I Blaser
Journal:  Neuroradiology       Date:  2016-08-11       Impact factor: 2.804

8.  Genetic modulation of islet β-cell iPLA₂β expression provides evidence for its impact on β-cell apoptosis and autophagy.

Authors:  Xiaoyong Lei; Robert N Bone; Tomader Ali; Mary Wohltmann; Ying Gai; Karen J Goodwin; Alan E Bohrer; John Turk; Sasanka Ramanadham
Journal:  Islets       Date:  2013-01-01       Impact factor: 2.694

9.  Genetic ablation of PLA2G6 in mice leads to cerebellar atrophy characterized by Purkinje cell loss and glial cell activation.

Authors:  Zhengshan Zhao; Jing Wang; Chunying Zhao; Weina Bi; Zhenyu Yue; Zhongmin Alex Ma
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

10.  New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations.

Authors:  Mustafa A Salih; Emeline Mundwiller; Arif O Khan; Abdulmajeed AlDrees; Salah A Elmalik; Hamdy H Hassan; Mohammed Al-Owain; Hisham M S Alkhalidi; Istvan Katona; Mohammad M Kabiraj; Roman Chrast; Amal Y Kentab; Hamad Alzaidan; Richard J Rodenburg; Thomas M Bosley; Joachim Weis; Michel Koenig; Giovanni Stevanin; Hamid Azzedine
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.